[1]
|
Bonati, L.H., Dobson, J., Featherstone, R.L., Ederle, J., van der Worp, H.B., de Borst, G.J., Mali, W.P.T.M., Beard, J.D., Cleveland, T., Engelter, S.T., Lyrer, P.A., Ford, G.A., Dorman, P.J. and Brown, M.M. (2015) Long-Term Outcomes after Stenting Versus Endarterectomy for Treatment of Symptomatic Carotid Stenosis: The International Carotid Stenting Study (ICSS) Randomised Trial. The Lancet, 385, 529-538. http://dx.doi.org/10.1016/S0140-6736(14)61184-3
|
[2]
|
Ma, N., Xu, Z., Mo, D., Gao, F., Gao, K., Sun, X., Xu, X., Liu, L., Song, L., Wang, T., Zhao, X., Wang, Y., Wang, Y. and Miao, Z. (2014) Safety of Low-Dose Aspirin in Endovascular Treatment for Intracranial Atherosclerotic Stenosis. PloS One, 9, e105252. http://dx.doi.org/10.1371/journal.pone.0105252
|
[3]
|
Kern, R., Steinke, W., Daffertshofer, M., Prager, R. and Hennerici, M. (2005) Stroke Recurrences in Patients with Symptomatic vs Asymptomatic Middle Cerebral Artery Disease. Neurology, 65, 859-864. http://dx.doi.org/10.1212/01.wnl.0000175983.76110.59
|
[4]
|
Tegos, T.J., Kalodiki, E., Daskalopoulou, S.S. and Nicolaides, A.N. (2000) Stroke: Epidemiology, Clinical Picture, and Risk Factors—Part I of III. Angiology, 51, 793-808. http://dx.doi.org/10.1177/000331970005101001
|
[5]
|
Qian, Y., Pu, Y., Liu, L., Wang, D.Z., Zhao, X., Wang, C., Wang, Y., Liu, G., Pan, Y. and Wang, Y. (2013) Low HDL-C Level Is Associated with the Development of Intracranial Artery Stenosis: Analysis from the Chinese IntraCranial Athero Sclerosis (CICAS) Study. PloS One, 8, e64395. http://dx.doi.org/10.1371/journal.pone.0064395
|
[6]
|
Erkan, A., Ekici, B., Ugurlu, M., Is, G., Seker, R., Demirtas, S. and Korkmaz, S. (2014) The Role of Bilirubin and Its Protective Function against Coronary Heart Disease. Herz, 39, 711-715. http://dx.doi.org/10.1007/s00059-013-3872-5
|
[7]
|
Giraudi, P.J., Bellarosa, C., Coda-Zabetta, C.D., Peruzzo, P. and Tiribelli, C. (2011) Functional Induction of the Cystine-Glutamate Exchanger System Xc(-) Activity in SH-SY5Y Cells by Unconjugated Bilirubin. PloS One, 6, e29078. http://dx.doi.org/10.1371/journal.pone.0029078
|
[8]
|
Huang, S.S., Huang, P.H., Wu, T.C., Chen, J.W. and Lin, S.J. (2012) Association of Serum Bilirubin with Contrast-Induced Nephropathy and Future Cardiovascular Events in Patients Undergoing Coronary Intervention. PloS One, 7, e42594. http://dx.doi.org/10.1371/journal.pone.0042594
|
[9]
|
Deetman, P.E., Bakker, S.J., Kwakernaak, A.J., Navis, G. and Dullaart, R.P. (2014) The Relationship of the Anti-Oxidant Bilirubin with Free Thyroxine Is Modified by Insulin Resistance in Euthyroid Subjects. PloS One, 9, e90886. http://dx.doi.org/10.1371/journal.pone.0090886
|
[10]
|
Erdogan, D., Gullu, H., Yildirim, E., Tok, D., Kirbas, I., Ciftci, O., Baycan, S.T. and Muderrisoglu, H. (2006) Low Serum Bilirubin Levels Are Independently and Inversely Related to Impaired Flow-Mediated Vasodilation and Increased Carotid Intima-Media Thickness in Both Men and Women. Atherosclerosis, 184, 431-437. http://dx.doi.org/10.1016/j.atherosclerosis.2005.05.011
|
[11]
|
Akboga, M.K., Canpolat, U., Sahinarslan, A., Alsancak, Y., Nurkoc, S., Aras, D., Aydogdu, S. and Abaci, A. (2015) Association of Serum Total Bilirubin Level with Severity of Coronary Atherosclerosis Is Linked to Systemic Inflammation. Atheroscleosis, 240, 110-114. http://dx.doi.org/10.1016/j.atherosclerosis.2015.02.051
|
[12]
|
Ryu, S., Chang, Y., Zhang, Y., Woo, H.Y., Kwon, M.J., Park, H., Lee, K.B., Son, H.J., Cho, J. and Guallar, E. (2014) Higher Serum Direct Bilirubin Levels Were Associated with a Lower Risk of Incident Chronic Kidney Disease in Middle Aged Korean Men. PloS One, 9, e75178. http://dx.doi.org/10.1371/journal.pone.0075178
|
[13]
|
Schwertner, H.A., Jackson, W.G. and Tolan, G. (1994) Association of Low Serum Concentration of Bilirubin with Increased Risk of Coronary Artery Disease. Clinical Chemistry, 40, 18-23.
|
[14]
|
Ishizaka, N., Ishizaka, Y., Takahashi, E., Yamakado, M. and Hashimoto, H. (2001) High Serum Bilirubin Level Is Inversely Associated with the Presence of Carotid Plaque. Stroke: A Journal of Cerebral Circulation, 32, 580-583. http://dx.doi.org/10.1161/01.STR.32.2.580-b
|
[15]
|
Perlstein, T.S., Pande, R.L., Beckman, J.A. and Creager, M.A. (2008) Serum Total Bilirubin Level and Prevalent Lower-Extremity Peripheral Arterial Disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 166-172. http://dx.doi.org/10.1161/ATVBAHA.107.153262
|
[16]
|
Kimm, H., Yun, J.E., Jo, J. and Jee, S.H. (2009) Low Serum Bilirubin Level as an Independent Predictor of Stroke Incidence: A Prospective Study in Korean Men and Women. Stroke: A Journal of Cerebral Circulation, 40, 3422-3427. http://dx.doi.org/10.1161/STROKEAHA.109.560649
|
[17]
|
Kuwano, T., Miura, S., Shirai, K., Ike, A., Mori, K., Shimizu, T., Zhang, B., Iwata, A., Nishikawa, H., Kawamura, A. and Saku, K. (2011) Serum Levels of Bilirubin as an Independent Predictor of Coronary In-Stent Restenosis: A New Look at an Old Molecule. Journal of Atherosclerosis and Thrombosis, 18, 574-583. http://dx.doi.org/10.5551/jat.6643
|
[18]
|
Rothwell, P.M., Gutnikov, S.A. and Warlow, C.P. (2003) Reanalysis of the Final Results of the European Carotid Surgery Trial. Stroke: A Journal of Cerebral Circulation, 34, 514-523. http://dx.doi.org/10.1161/01.STR.0000054671.71777.C7
|
[19]
|
Li, S., Guo, Y.L., Xu, R.X., Zhang, Y., Zhu, C.G., Sun, J., Qing, P., Wu, N.Q., Jiang, L.X. and Li, J.J. (2014) Association of Plasma PCSK9 Levels with White Blood Cell Count and Its Subsets in Patients with Stable Coronary Artery Disease. Atherosclerosis, 234, 441-445. http://dx.doi.org/10.1016/j.atherosclerosis.2014.04.001
|
[20]
|
Ishizaka, N., Ishizaka, Y., Toda, E., Nagai, R. and Yamakado, M. (2005) Association between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 1038-1044. http://dx.doi.org/10.1161/01.ATV.0000161274.87407.26
|
[21]
|
Neuzil, J. and Stocker, R. (1994) Free and Albumin-Bound Bilirubin Are Efficient Co-Antioxidants for Alpha-Tocopherol, Inhibiting Plasma and Low Density Lipoprotein Lipid Peroxidation. The Journal of Biological Chemistry, 269, 16712-16719.
|
[22]
|
Nakayama, M., Takahashi, K., Komaru, T., Fukuchi, M., Shioiri, H., Sato, K., Kitamuro, T., Shirato, K., Yamaguchi, T., Suematsu, M. and Shibahara, S. (2001) Increased Expression of Heme Oxygenase-1 and Bilirubin Accumulation in Foam Cells of Rabbit Atherosclerotic Lesions. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 1373-1377. http://dx.doi.org/10.1161/hq0801.093592
|
[23]
|
Ollinger, R., Yamashita, K., Bilban, M., Erat, A., Kogler, P., Thomas, M., Csizmadia, E., Usheva, A., Margreiter, R. and Bach, F.H. (2007) Bilirubin and Biliverdin Treatment of Atherosclerotic Diseases. Cell Cycle, 6, 39-43. http://dx.doi.org/10.4161/cc.6.1.3700
|
[24]
|
Vitek, L. and Schwertner, H.A. (2007) The Heme Catabolic Pathway and Its Protective Effects on Oxidative Stress-Mediated Diseases. Advances in Clinical Chemistry, 43, 1-57. http://dx.doi.org/10.1016/S0065-2423(06)43001-8
|
[25]
|
Ollinger, R., Bilban, M., Erat, A., Froio, A., McDaid, J., Tyagi, S., Csizmadia, E., Graca-Souza, A.V., Liloia, A., Soares, M.P., Otterbein, L.E., Usheva, A., Yamashita, K. and Bach, F.H. (2005) Bilirubin: A Natural Inhibitor of Vascular Smooth Muscle Cell Proliferation. Circulation, 112, 1030-1039. http://dx.doi.org/10.1161/CIRCULATIONAHA.104.528802
|
[26]
|
Peyton, K.J., Shebib, A.R., Azam, M.A., Liu, X.M., Tulis, D.A. and Durante, W. (2012) Bilirubin Inhibits Neointima Formation and Vascular Smooth Muscle Cell Proliferation and Migration. Frontiers in Pharmacology, 3, 48. http://dx.doi.org/10.3389/fphar.2012.00048
|
[27]
|
Yang, X.F., Chen, Y.Z., Su, J.L., Wang, F.Y. and Wang, L.X. (2009) Relationship between Serum Bilirubin and Carotid Atherosclerosis in Hypertensive Patients. Internal Medicine, 48, 1595-1599. http://dx.doi.org/10.2169/internalmedicine.48.2286
|
[28]
|
Stocker, R., Yamamoto, Y., McDonagh, A.F., Glazer, A.N. and Ames, B.N. (1987) Bilirubin Is an Antioxidant of Possible Physiological Importance. Science, 235, 1043-1046. http://dx.doi.org/10.1126/science.3029864
|
[29]
|
Frei, B., Stocker, R. and Ames, B.N. (1988) Antioxidant Defenses and Lipid Peroxidation in Human Blood Plasma. Proceedings of the National Academy of Sciences of the United States of America, 85, 9748-9752. http://dx.doi.org/10.1073/pnas.85.24.9748
|
[30]
|
Yamaguchi, T., Terakado, M., Horio, F., Aoki, K., Tanaka, M. and Nakajima, H. (1996) Role of Bilirubin as an Antioxidant in an Ischemia-Reperfusion of Rat Liver and Induction of Heme Oxygenase. Biochemical and Biophysical Research Communications, 223, 129-135. http://dx.doi.org/10.1006/bbrc.1996.0857
|
[31]
|
Trappolini, M., Stoppo, M., Meggiorini, M., Loguercio, V., Fabiani, O., Iannotta, M., Negro, A., Sebastianelli, A., Proietta, M., Del Porto, F. and Aliberti, G. (2009) The Plasma Fibrinogen as a Marker of Subclinical Carotid Atherosclerosis. Recenti Progressi in Medicina, 100, 352-355.
|
[32]
|
Redgrave, J.N., Lovett, J.K. and Rothwell, P.M. (2010) Histological Features of Symptomatic Carotid Plaques in Relation to Age and Smoking: The Oxford Plaque Study. Stroke: A Journal of Cerebral Circulation, 41, 2288-2294. http://dx.doi.org/10.1161/STROKEAHA.110.587006
|